APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Device Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cardiovascular Device Testing Service Market Outlook and Growth Opportunities 2026

Report ID 174086590415 April 2026Not stated

Choose your research edition.

Industry ResearchCardiovascular Device Testing Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Device Testing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Cardiovascular Device Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Device Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Device Testing Service Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Cardiovascular Device Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cardiovascular Device Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cardiovascular Device Testing Service market include TÜV SÜD, ViVitro Labs, STC Group, Intertek, NAMSA, BDC Laboratories, MET Labs, SGS SA and Nelson Labs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cardiovascular Device Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiovascular Device Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiovascular Device Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cardiovascular Device Testing Service market.

Cardiovascular Device Testing Service Segment by Company

TÜV SÜD

ViVitro Labs

STC Group

Intertek

NAMSA

BDC Laboratories

MET Labs

SGS SA

Nelson Labs

Charles River Laboratories

UL Solutions

MED Institute

Eurofins Scientific

Pharmaron

Pace Analytical

Porsolt

Medical Murray

Measurlabs

RQM+

Laboratory Testing

Infinity Laboratories

Ibex Preclinical Research

Innovatech Labs

Cardiovascular Device Testing Service Segment by Type

Mechanical Testing

Physical Testing

Environmental Testing

Biocompatibility Testing

Performance Testing

Electromagnetic Compatibility (EMC) Testing

Preclinical Testing

Clinical Testing

Others

Cardiovascular Device Testing Service Segment by Application

Interventional Devices

Implantable Devices

Diagnostic and Monitoring Devices

Extracorporeal Circulation and Support Devices

Vascular Access and Suture Devices

Others

Cardiovascular Device Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cardiovascular Device Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cardiovascular Device Testing Service key companies, revenue, market share, and recent developments.

3. To split the Cardiovascular Device Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cardiovascular Device Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiovascular Device Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiovascular Device Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Device Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Device Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Device Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiovascular Device Testing Service industry.

Chapter 3: Detailed analysis of Cardiovascular Device Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cardiovascular Device Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cardiovascular Device Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiovascular Device Testing Service Industry Trends Table 2. Cardiovascular Device Testing Service Industry Drivers Table 3. Cardiovascular Device Testing Service Industry Opportunities and Challenges Table 4. Cardiovascular Device Testing Service Industry Restraints Table 5. Global Cardiovascular Device Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiovascular Device Testing Service Revenue Share by Company (2021-2026) Table 7. Global Cardiovascular Device Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cardiovascular Device Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Cardiovascular Device Testing Service Company, Product Type & Application Table 10. Global Cardiovascular Device Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cardiovascular Device Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mechanical Testing Table 15. Significant Companies of Physical Testing Table 16. Significant Companies of Environmental Testing Table 17. Significant Companies of Biocompatibility Testing Table 18. Significant Companies of Performance Testing Table 19. Significant Companies of Electromagnetic Compatibility (EMC) Testing Table 20. Significant Companies of Preclinical Testing Table 21. Significant Companies of Clinical Testing Table 22. Significant Companies of Others Table 23. Global Cardiovascular Device Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Cardiovascular Device Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 25. Global Cardiovascular Device Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 26. Global Cardiovascular Device Testing Service Sales Value Share by Type (2021-2026) Table 27. Global Cardiovascular Device Testing Service Sales Value Share by Type (2027-2032) Table 28. Significant Companies of Interventional Devices Table 29. Significant Companies of Implantable Devices Table 30. Significant Companies of Diagnostic and Monitoring Devices Table 31. Significant Companies of Extracorporeal Circulation and Support Devices Table 32. Significant Companies of Vascular Access and Suture Devices Table 33. Significant Companies of Others Table 34. Global Cardiovascular Device Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cardiovascular Device Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 36. Global Cardiovascular Device Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 37. Global Cardiovascular Device Testing Service Sales Value Share by Application (2021-2026) Table 38. Global Cardiovascular Device Testing Service Sales Value Share by Application (2027-2032) Table 39. Global Cardiovascular Device Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cardiovascular Device Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 41. Global Cardiovascular Device Testing Service Sales Value Share by Region (2021-2026) Table 42. Global Cardiovascular Device Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 43. Global Cardiovascular Device Testing Service Sales Value Share by Region (2027-2032) Table 44. Global Cardiovascular Device Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Cardiovascular Device Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 46. Global Cardiovascular Device Testing Service Sales Value Market Share by Country (2021-2026) Table 47. Global Cardiovascular Device Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 48. Global Cardiovascular Device Testing Service Sales Value Market Share by Country (2027-2032) Table 49. TÜV SÜD Company Information Table 50. TÜV SÜD Business Overview Table 51. TÜV SÜD Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. TÜV SÜD Cardiovascular Device Testing Service Product Portfolio Table 53. TÜV SÜD Recent Development Table 54. ViVitro Labs Company Information Table 55. ViVitro Labs Business Overview Table 56. ViVitro Labs Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ViVitro Labs Cardiovascular Device Testing Service Product Portfolio Table 58. ViVitro Labs Recent Development Table 59. STC Group Company Information Table 60. STC Group Business Overview Table 61. STC Group Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. STC Group Cardiovascular Device Testing Service Product Portfolio Table 63. STC Group Recent Development Table 64. Intertek Company Information Table 65. Intertek Business Overview Table 66. Intertek Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Intertek Cardiovascular Device Testing Service Product Portfolio Table 68. Intertek Recent Development Table 69. NAMSA Company Information Table 70. NAMSA Business Overview Table 71. NAMSA Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. NAMSA Cardiovascular Device Testing Service Product Portfolio Table 73. NAMSA Recent Development Table 74. BDC Laboratories Company Information Table 75. BDC Laboratories Business Overview Table 76. BDC Laboratories Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BDC Laboratories Cardiovascular Device Testing Service Product Portfolio Table 78. BDC Laboratories Recent Development Table 79. MET Labs Company Information Table 80. MET Labs Business Overview Table 81. MET Labs Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. MET Labs Cardiovascular Device Testing Service Product Portfolio Table 83. MET Labs Recent Development Table 84. SGS SA Company Information Table 85. SGS SA Business Overview Table 86. SGS SA Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. SGS SA Cardiovascular Device Testing Service Product Portfolio Table 88. SGS SA Recent Development Table 89. Nelson Labs Company Information Table 90. Nelson Labs Business Overview Table 91. Nelson Labs Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Nelson Labs Cardiovascular Device Testing Service Product Portfolio Table 93. Nelson Labs Recent Development Table 94. Charles River Laboratories Company Information Table 95. Charles River Laboratories Business Overview Table 96. Charles River Laboratories Cardiovascular Device Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Charles River Laboratories Cardiovascular Device Testing Service Product Portfolio Table 98. Charles River Laboratories Recent Development Table 99. UL Solutions Company Information Table 100. UL Solutions Business Overview Table 101. UL Solutions Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. UL Solutions Cardiovascular Device Testing Service Product Portfolio Table 103. UL Solutions Recent Development Table 104. MED Institute Company Information Table 105. MED Institute Business Overview Table 106. MED Institute Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. MED Institute Cardiovascular Device Testing Service Product Portfolio Table 108. MED Institute Recent Development Table 109. Eurofins Scientific Company Information Table 110. Eurofins Scientific Business Overview Table 111. Eurofins Scientific Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Eurofins Scientific Cardiovascular Device Testing Service Product Portfolio Table 113. Eurofins Scientific Recent Development Table 114. Pharmaron Company Information Table 115. Pharmaron Business Overview Table 116. Pharmaron Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Pharmaron Cardiovascular Device Testing Service Product Portfolio Table 118. Pharmaron Recent Development Table 119. Pace Analytical Company Information Table 120. Pace Analytical Business Overview Table 121. Pace Analytical Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Pace Analytical Cardiovascular Device Testing Service Product Portfolio Table 123. Pace Analytical Recent Development Table 124. Porsolt Company Information Table 125. Porsolt Business Overview Table 126. Porsolt Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Porsolt Cardiovascular Device Testing Service Product Portfolio Table 128. Porsolt Recent Development Table 129. Medical Murray Company Information Table 130. Medical Murray Business Overview Table 131. Medical Murray Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Medical Murray Cardiovascular Device Testing Service Product Portfolio Table 133. Medical Murray Recent Development Table 134. Measurlabs Company Information Table 135. Measurlabs Business Overview Table 136. Measurlabs Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Measurlabs Cardiovascular Device Testing Service Product Portfolio Table 138. Measurlabs Recent Development Table 139. RQM+ Company Information Table 140. RQM+ Business Overview Table 141. RQM+ Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. RQM+ Cardiovascular Device Testing Service Product Portfolio Table 143. RQM+ Recent Development Table 144. Laboratory Testing Company Information Table 145. Laboratory Testing Business Overview Table 146. Laboratory Testing Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Laboratory Testing Cardiovascular Device Testing Service Product Portfolio Table 148. Laboratory Testing Recent Development Table 149. Infinity Laboratories Company Information Table 150. Infinity Laboratories Business Overview Table 151. Infinity Laboratories Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Infinity Laboratories Cardiovascular Device Testing Service Product Portfolio Table 153. Infinity Laboratories Recent Development Table 154. Ibex Preclinical Research Company Information Table 155. Ibex Preclinical Research Business Overview Table 156. Ibex Preclinical Research Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Ibex Preclinical Research Cardiovascular Device Testing Service Product Portfolio Table 158. Ibex Preclinical Research Recent Development Table 159. Innovatech Labs Company Information Table 160. Innovatech Labs Business Overview Table 161. Innovatech Labs Cardiovascular Device Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Innovatech Labs Cardiovascular Device Testing Service Product Portfolio Table 163. Innovatech Labs Recent Development Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Cardiovascular Device Testing Service Product Image Figure 2. Global Cardiovascular Device Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiovascular Device Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiovascular Device Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mechanical Testing Image Figure 8. Physical Testing Image Figure 9. Environmental Testing Image Figure 10. Biocompatibility Testing Image Figure 11. Performance Testing Image Figure 12. Electromagnetic Compatibility (EMC) Testing Image Figure 13. Preclinical Testing Image Figure 14. Clinical Testing Image Figure 15. Others Image Figure 16. Global Cardiovascular Device Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cardiovascular Device Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cardiovascular Device Testing Service Sales Value Share by Type (2021-2032) Figure 19. Interventional Devices Image Figure 20. Implantable Devices Image Figure 21. Diagnostic and Monitoring Devices Image Figure 22. Extracorporeal Circulation and Support Devices Image Figure 23. Vascular Access and Suture Devices Image Figure 24. Others Image Figure 25. Global Cardiovascular Device Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cardiovascular Device Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Cardiovascular Device Testing Service Sales Value Share by Application (2021-2032) Figure 28. Global Cardiovascular Device Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cardiovascular Device Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cardiovascular Device Testing Service Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cardiovascular Device Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cardiovascular Device Testing Service Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cardiovascular Device Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cardiovascular Device Testing Service Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cardiovascular Device Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cardiovascular Device Testing Service Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cardiovascular Device Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cardiovascular Device Testing Service Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cardiovascular Device Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Years Considered Figure 125. Research Process Figure 126. Key Executives Interviewed

Scope & coverage.

Types
  • Mechanical Testing
  • Physical Testing
  • Environmental Testing
  • Biocompatibility Testing
  • Performance Testing
  • Electromagnetic Compatibility (EMC) Testing
  • Preclinical Testing
  • Clinical Testing
  • Others
Applications
  • Interventional Devices
  • Implantable Devices
  • Diagnostic and Monitoring Devices
  • Extracorporeal Circulation and Support Devices
  • Vascular Access and Suture Devices
  • Others
Companies covered
  • TÜV SÜD
  • ViVitro Labs
  • STC Group
  • Intertek
  • NAMSA
  • BDC Laboratories
  • MET Labs
  • SGS SA
  • Nelson Labs
  • Charles River Laboratories
  • UL Solutions
  • MED Institute
  • Eurofins Scientific
  • Pharmaron
  • Pace Analytical
  • Porsolt
  • Medical Murray
  • Measurlabs
  • RQM+
  • Laboratory Testing
  • Infinity Laboratories
  • Ibex Preclinical Research
  • Innovatech Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cardiovascular Device Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cardiovascular Device Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cardiovascular Device Testing Service Market Dynamics
  1. 2.1 Cardiovascular Device Testing Service Industry Trends
  2. 2.2 Cardiovascular Device Testing Service Industry Drivers
  3. 2.3 Cardiovascular Device Testing Service Industry Opportunities and Challenges
  4. 2.4 Cardiovascular Device Testing Service Industry Restraints
3 Cardiovascular Device Testing Service Market by Company
  1. 3.1 Global Cardiovascular Device Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Cardiovascular Device Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Cardiovascular Device Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Cardiovascular Device Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Cardiovascular Device Testing Service Company Product Type and Application
  6. 3.6 Global Cardiovascular Device Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cardiovascular Device Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cardiovascular Device Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cardiovascular Device Testing Service Market by Type
  1. 4.1 Cardiovascular Device Testing Service Type Introduction
  2. 4.1.1 Mechanical Testing
  3. 4.1.2 Physical Testing
  4. 4.1.3 Environmental Testing
  5. 4.1.4 Biocompatibility Testing
  6. 4.1.5 Performance Testing
  7. 4.1.6 Electromagnetic Compatibility (EMC) Testing
  8. 4.1.7 Preclinical Testing
  9. 4.1.8 Clinical Testing
  10. 4.1.9 Others
  11. 4.2 Global Cardiovascular Device Testing Service Sales Value by Type
  12. 4.2.1 Global Cardiovascular Device Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Cardiovascular Device Testing Service Sales Value by Type (2021-2032)
  14. 4.2.3 Global Cardiovascular Device Testing Service Sales Value Share by Type (2021-2032)
5 Cardiovascular Device Testing Service Market by Application
  1. 5.1 Cardiovascular Device Testing Service Application Introduction
  2. 5.1.1 Interventional Devices
  3. 5.1.2 Implantable Devices
  4. 5.1.3 Diagnostic and Monitoring Devices
  5. 5.1.4 Extracorporeal Circulation and Support Devices
  6. 5.1.5 Vascular Access and Suture Devices
  7. 5.1.6 Others
  8. 5.2 Global Cardiovascular Device Testing Service Sales Value by Application
  9. 5.2.1 Global Cardiovascular Device Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Cardiovascular Device Testing Service Sales Value by Application (2021-2032)
  11. 5.2.3 Global Cardiovascular Device Testing Service Sales Value Share by Application (2021-2032)
6 Cardiovascular Device Testing Service Regional Value Analysis
  1. 6.1 Global Cardiovascular Device Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiovascular Device Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cardiovascular Device Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cardiovascular Device Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cardiovascular Device Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Cardiovascular Device Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cardiovascular Device Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Cardiovascular Device Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cardiovascular Device Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cardiovascular Device Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cardiovascular Device Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Cardiovascular Device Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cardiovascular Device Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cardiovascular Device Testing Service Sales Value Share by Country, 2025 VS 2032
7 Cardiovascular Device Testing Service Country-level Value Analysis
  1. 7.1 Global Cardiovascular Device Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiovascular Device Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cardiovascular Device Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cardiovascular Device Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cardiovascular Device Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cardiovascular Device Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cardiovascular Device Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 TÜV SÜD
  2. 8.1.1 TÜV SÜD Company Information
  3. 8.1.2 TÜV SÜD Business Overview
  4. 8.1.3 TÜV SÜD Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TÜV SÜD Cardiovascular Device Testing Service Product Portfolio
  6. 8.1.5 TÜV SÜD Recent Developments
  7. 8.2 ViVitro Labs
  8. 8.2.1 ViVitro Labs Company Information
  9. 8.2.2 ViVitro Labs Business Overview
  10. 8.2.3 ViVitro Labs Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ViVitro Labs Cardiovascular Device Testing Service Product Portfolio
  12. 8.2.5 ViVitro Labs Recent Developments
  13. 8.3 STC Group
  14. 8.3.1 STC Group Company Information
  15. 8.3.2 STC Group Business Overview
  16. 8.3.3 STC Group Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 STC Group Cardiovascular Device Testing Service Product Portfolio
  18. 8.3.5 STC Group Recent Developments
  19. 8.4 Intertek
  20. 8.4.1 Intertek Company Information
  21. 8.4.2 Intertek Business Overview
  22. 8.4.3 Intertek Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Intertek Cardiovascular Device Testing Service Product Portfolio
  24. 8.4.5 Intertek Recent Developments
  25. 8.5 NAMSA
  26. 8.5.1 NAMSA Company Information
  27. 8.5.2 NAMSA Business Overview
  28. 8.5.3 NAMSA Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NAMSA Cardiovascular Device Testing Service Product Portfolio
  30. 8.5.5 NAMSA Recent Developments
  31. 8.6 BDC Laboratories
  32. 8.6.1 BDC Laboratories Company Information
  33. 8.6.2 BDC Laboratories Business Overview
  34. 8.6.3 BDC Laboratories Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BDC Laboratories Cardiovascular Device Testing Service Product Portfolio
  36. 8.6.5 BDC Laboratories Recent Developments
  37. 8.7 MET Labs
  38. 8.7.1 MET Labs Company Information
  39. 8.7.2 MET Labs Business Overview
  40. 8.7.3 MET Labs Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MET Labs Cardiovascular Device Testing Service Product Portfolio
  42. 8.7.5 MET Labs Recent Developments
  43. 8.8 SGS SA
  44. 8.8.1 SGS SA Company Information
  45. 8.8.2 SGS SA Business Overview
  46. 8.8.3 SGS SA Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SGS SA Cardiovascular Device Testing Service Product Portfolio
  48. 8.8.5 SGS SA Recent Developments
  49. 8.9 Nelson Labs
  50. 8.9.1 Nelson Labs Company Information
  51. 8.9.2 Nelson Labs Business Overview
  52. 8.9.3 Nelson Labs Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nelson Labs Cardiovascular Device Testing Service Product Portfolio
  54. 8.9.5 Nelson Labs Recent Developments
  55. 8.10 Charles River Laboratories
  56. 8.10.1 Charles River Laboratories Company Information
  57. 8.10.2 Charles River Laboratories Business Overview
  58. 8.10.3 Charles River Laboratories Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Charles River Laboratories Cardiovascular Device Testing Service Product Portfolio
  60. 8.10.5 Charles River Laboratories Recent Developments
  61. 8.11 UL Solutions
  62. 8.11.1 UL Solutions Company Information
  63. 8.11.2 UL Solutions Business Overview
  64. 8.11.3 UL Solutions Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 UL Solutions Cardiovascular Device Testing Service Product Portfolio
  66. 8.11.5 UL Solutions Recent Developments
  67. 8.12 MED Institute
  68. 8.12.1 MED Institute Company Information
  69. 8.12.2 MED Institute Business Overview
  70. 8.12.3 MED Institute Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MED Institute Cardiovascular Device Testing Service Product Portfolio
  72. 8.12.5 MED Institute Recent Developments
  73. 8.13 Eurofins Scientific
  74. 8.13.1 Eurofins Scientific Company Information
  75. 8.13.2 Eurofins Scientific Business Overview
  76. 8.13.3 Eurofins Scientific Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Eurofins Scientific Cardiovascular Device Testing Service Product Portfolio
  78. 8.13.5 Eurofins Scientific Recent Developments
  79. 8.14 Pharmaron
  80. 8.14.1 Pharmaron Company Information
  81. 8.14.2 Pharmaron Business Overview
  82. 8.14.3 Pharmaron Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pharmaron Cardiovascular Device Testing Service Product Portfolio
  84. 8.14.5 Pharmaron Recent Developments
  85. 8.15 Pace Analytical
  86. 8.15.1 Pace Analytical Company Information
  87. 8.15.2 Pace Analytical Business Overview
  88. 8.15.3 Pace Analytical Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pace Analytical Cardiovascular Device Testing Service Product Portfolio
  90. 8.15.5 Pace Analytical Recent Developments
  91. 8.16 Porsolt
  92. 8.16.1 Porsolt Company Information
  93. 8.16.2 Porsolt Business Overview
  94. 8.16.3 Porsolt Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Porsolt Cardiovascular Device Testing Service Product Portfolio
  96. 8.16.5 Porsolt Recent Developments
  97. 8.17 Medical Murray
  98. 8.17.1 Medical Murray Company Information
  99. 8.17.2 Medical Murray Business Overview
  100. 8.17.3 Medical Murray Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Medical Murray Cardiovascular Device Testing Service Product Portfolio
  102. 8.17.5 Medical Murray Recent Developments
  103. 8.18 Measurlabs
  104. 8.18.1 Measurlabs Company Information
  105. 8.18.2 Measurlabs Business Overview
  106. 8.18.3 Measurlabs Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Measurlabs Cardiovascular Device Testing Service Product Portfolio
  108. 8.18.5 Measurlabs Recent Developments
  109. 8.19 RQM+
  110. 8.19.1 RQM+ Company Information
  111. 8.19.2 RQM+ Business Overview
  112. 8.19.3 RQM+ Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 RQM+ Cardiovascular Device Testing Service Product Portfolio
  114. 8.19.5 RQM+ Recent Developments
  115. 8.20 Laboratory Testing
  116. 8.20.1 Laboratory Testing Company Information
  117. 8.20.2 Laboratory Testing Business Overview
  118. 8.20.3 Laboratory Testing Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Laboratory Testing Cardiovascular Device Testing Service Product Portfolio
  120. 8.20.5 Laboratory Testing Recent Developments
  121. 8.21 Infinity Laboratories
  122. 8.21.1 Infinity Laboratories Company Information
  123. 8.21.2 Infinity Laboratories Business Overview
  124. 8.21.3 Infinity Laboratories Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Infinity Laboratories Cardiovascular Device Testing Service Product Portfolio
  126. 8.21.5 Infinity Laboratories Recent Developments
  127. 8.22 Ibex Preclinical Research
  128. 8.22.1 Ibex Preclinical Research Company Information
  129. 8.22.2 Ibex Preclinical Research Business Overview
  130. 8.22.3 Ibex Preclinical Research Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Ibex Preclinical Research Cardiovascular Device Testing Service Product Portfolio
  132. 8.22.5 Ibex Preclinical Research Recent Developments
  133. 8.23 Innovatech Labs
  134. 8.23.1 Innovatech Labs Company Information
  135. 8.23.2 Innovatech Labs Business Overview
  136. 8.23.3 Innovatech Labs Cardiovascular Device Testing Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Innovatech Labs Cardiovascular Device Testing Service Product Portfolio
  138. 8.23.5 Innovatech Labs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst